Johan Erik Häggblad
Directeur Technique/Scientifique/R&D chez CALLIDITAS THERAPEUTICS AB
Provenance du réseau au premier degré de Johan Erik Häggblad
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.
81
| Extinct | Pharmaceuticals: Major | 81 |
| Public Company | Pharmaceuticals: Major | 36 | |
Epicyt Pharma AB
 Epicyt Pharma AB Pharmaceuticals: MajorHealth Technology Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
| Public Company | Pharmaceuticals: Major | 3 | |
Nefecon AB
 Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Busulipo AB
 Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden.
1
| Private Company | Pharmaceuticals: Major | 1 |
Pharmalink Nordic AB
1
| Private Company | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Johan Erik Häggblad via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Human Resources Officer Sales & Marketing Compliance Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| MONSANTO | Wholesale Distributors | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Public Communications Contact General Counsel Chief Administrative Officer Human Resources Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Tech/Sci/R&D Officer Chairman Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Chief Executive Officer Human Resources Officer | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| Karolinska Institutet | College/University | Director/Board Member Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| MEDCAP AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| SMITH & NEPHEW PLC | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member President Chief Tech/Sci/R&D Officer | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal President Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Public Communications Contact | |
| University of Delaware | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Georgia State University | College/University | Graduate Degree Graduate Degree Masters Business Admin | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Public Communications Contact Director/Board Member Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Chairman Corporate Officer/Principal | |
| WEIFA ASA | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Public Communications Contact | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman Corporate Officer/Principal | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member Chairman | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
ViroVet NV
 ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
| ZOETIS INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal Public Communications Contact | |
| DUN & BRADSTREET CORP | Data Processing Services | Director/Board Member Director of Finance/CFO |
Statistiques
Internationale
| Etats-Unis | 25 |
| Suède | 15 |
| Royaume-Uni | 4 |
| Canada | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 35 |
| Consumer Services | 10 |
| Commercial Services | 3 |
| Distribution Services | 2 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 568 |
| Corporate Officer/Principal | 249 |
| Independent Dir/Board Member | 181 |
| Chairman | 164 |
| Chief Executive Officer | 104 |
Relations les plus connectées
| Insiders | |
|---|---|
| Thomas Lennart Eklund | 57 |
| Carola Elisabet Lemne | 47 |
| Bengt Åke Julander | 36 |
| Stig Lennart Hansson | 32 |
| Elmar Schnee | 31 |
| Michael Friedman | 30 |
| Anders Paul Wiklund | 29 |
| Mark Corrigan | 29 |
| Fred Hassan | 29 |
| Joseph Papa | 28 |
| Paul Edick | 27 |
| Håkan Åström | 26 |
| Thomas Paul Koestler | 26 |
| Renée Aguiar-Lucander | 26 |
| Charles Rowland | 25 |
- Bourse
- Insiders
- Johan Erik Häggblad
- Connexions Sociétés
